CED Venture 2003 Presenting Company Profiles.

Business Editors

CED Venture 2003

CHAPEL HILL, N.C.--(BUSINESS WIRE)--April 22, 2003

The CED 20th annual Venture conference takes place April 22-23 at the Friday Center in Chapel Hill, North Carolina. For more information visit http://www.cednc.org/venture/2003/.

Business Wire is the official news service for this event. Listed below are profiles from presenting companies. News releases, advisories, and press kits are available at www.businesswire.com.

Company:                      Business North Carolina magazine
Media Contact:                Ben Kinney
Phone:                        704-523-6987
E-mail:                       [e-mail]
Company URL:                  www.businessnc.com

Company description:
For 23 years, Business North Carolina has reported on the trends,
people and companies that make up our state's economy. Unlike some
business magazines, we do not speak for any special-interest group or
espouse a specific viewpoint. Our job is to reflect reality and, in
doing so, to entertain and enlighten our readers.


Company:                      Dynogen Pharmaceuticals, Inc.
Booth:                        18
Media Contact:                Lee Brettman, CEO
Investor Relations Contact:   Lee Brettman, CEO
Phone:                        617-357-8000
E-mail:                       [e-mail]
Company URL:                  www.dynogenpharma.com

Product description:
Product candidates include therapies for the treatment of
genitourinary and gastrointestinal disorders.

Company description:
Dynogen applies its proprietary predictive modeling platform and
expertise in neurobiology to the discovery and development of
genitourinary (GU) and gastrointestinal (GI) therapies for which
current treatments are either non-existent or inadequate. GU and GI
disorders afflict more than 60 million Americans and there are few
options available to effectively treat these disorders.  The Company
is focused on overactive bladder, irritable bowel syndrome,
inflammatory bowel disease and various forms of sexual dysfunction.


Company:                      Elsinore Technologies
Media Contact:                Christina Gagliano
Email:                        [e-mail]
Mobile:                       617-851-1135
Office:                       781-620-1411
Investor Relations Contact:   Dan Soper, President & COO
Phone:                        919-532-0022
E-mail:                       [e-mail]
Company URL:                  www.elsitech.com

Product description:
Elsinore's Visual Intercept enterprise issue management platform is
the industry's only completely scalable, closed-loop system for
managing issues (the planned tasks and unexpected events) associated
with work across the enterprise. Thousands of customers at more than
2,500 companies worldwide have purchased Visual Intercept licenses.

Company description:
Founded in 1995 to develop software for Microsoft-centric development
team members to better manage defects discovered during software
development, Elsinore is evolving into a provider of "enterprise issue
management solutions" that allow all users to identify, manage and
communicate issues associated with work in real time over a common
platform.


Company:                      Intersouth Partners
Media Contact:                Andrea Cook
Investor Relations Contact:   Andrea Cook
Phone:                        [phone]
E-mail:                       [e-mail]
Company URL:                  www.intersouth.com

Based in Durham, NC, Intersouth Partners is one of the most active
and experienced early-stage venture funds in the Southeast having
invested in over 70 private companies in the life sciences and
information technology sectors. Founded in 1985, Intersouth manages
$500 million in six venture capital limited partnerships.


Company:                      Kennedy Covington Lobdell & Hickman, LLP
Media Contact:                Camille Stell
Investor Relations Contact:   Kent Christison
Phone:                        919/743-7329
E-mail:                       [e-mail]
Company URL:                  www.kennedycovington.com

Product description:
Legal Services

Company description:
Kennedy Covington Lobdell & Hickman, L.L.P. is one of the largest
full service law firms in the Carolinas, with offices in Charlotte,
Raleigh, Research Triangle Park, Columbia and Rock Hill. Our lawyers
bring a depth of experience and a knowledge of the law to bear in
solving problems and leveraging opportunities for clients in varied
industries such as banking, real estate, health care, technology and
manufacturing. At Kennedy Covington, we give more than a legal
opinion; we provide a business perspective.


Company:                      Kilpatrick Stockton LLP
Media Contact:                John Page, 404-815-5903
                               or Jenny Harden, 404-745-2495
Phone:                        919-420-1700
E-Mail:                       [e-mail]
Company URL:                  www.kilpatrickstockton.com

Company Description:
Kilpatrick Stockton LLP is a full-service international law firm
with more than 475 attorneys in eight offices across the globe:
Atlanta and Augusta, GA.; Charlotte, Raleigh and Winston-Salem, NC;
Washington, D.C.; London, England; and Stockholm, Sweden. Kilpatrick
Stockton's delivery of innovative business solutions provides
results-oriented counsel for corporations, from the challenging
demands of financial transactions and securities to the disciplines of
intellectual property management. Collaboration among Kilpatrick
Stockton's corporate, litigation and intellectual property attorneys
provides knowledgeable and proactive guidance for companies at every
stage of the business life cycle.



Company:                      Kucera Pharmaceutical Co.
Media Contact:                Russ H. Read, CEO
Phone:                        336-723-7133
E-mail:                       [e-mail]
Company URL:                  www.kucerapharma.com

Product description:
Novel product (KPC-2) in early pre clinical development for
treatment resistant HIV.

Company description:
The Kucera Pharmaceutical Company is an early stage biotech
company with head office based out of Winston Salem N.C. Its interest
is in the preclinical and early clinical development of its patented
small molecules for the treatment of specific viral illnesses and
cancers.


Company:                      SmartPath
Media Contact:                Grace Ueng
Investor Relations Contact:   Grace Ueng
Phone:                        919 462 1489 x214
E-mail:                       [e-mail]
Company URL:                  www.smartpathinc.com

Company description:
SmartPath is the visionary leader among marketing resource
management vendors and provides the most comprehensive, robust, and
flexible solution to companies whose marketing activities are critical
to their success. SmartPath allows companies to more effectively
manage the planning and budgeting, development, management,
distribution, and measurement of all their marketing initiatives -
facilitating speed to market with more effective use of resources.
SmartPath is the provider of choice for some of the world's most
innovative companies including GlaxoSmithKline, Wyeth, Leo Burnett,
Victoria's Secret, Kohler, and National Geographic. SmartPath is
headquartered in Research Triangle Park, NC with European offices in
London. For more information, visit www.smartpathinc.com.


Company:                      Syntherica Corporation
Media Contact:                D. Joe Smith, Chairman & CEO
Investor Relations Contact:   D. Joe Smith, Chairman & CEO
Phone:                        [phone]
E-mail:                       [e-mail]
Company URL:                  www.syntherica.com

Product Description:
Syntherica's core technology is its proprietary Synthetide(tm)
surrogate antibody platform. Synthetide(tm) molecules are nucleic acid
polymeric structures sharing many of the features of classical
antibodies but possessing additional characteristics that overcome the
significant limitations of natural antibodies. For example, the
discovery and development process for monoclonal antibodies is slow
and cumbersome (man-years), while Synthetide(tm) technology is fast
and efficient (man-months). Unlike monoclonal antibodies, the binding
regions of Synthetide(tm) molecules are not size-constrained, making
Synthetides(tm) promising candidates for detecting/attacking novel
cellular or microbial targets unachievable with antibody-based
technologies. Synthetide(tm)-based immunoassays provide a way to
diagnose diseases for which no reliable early-stage method of
diagnosis now exists.

Company Description:
Syntherica Corporation, an early-stage biotechnology company, is
located near Research Triangle Park in Durham, North Carolina.
Syntherica began operations in September 2002, having acquired the
Synthetide(tm) surrogate antibody technology invented by President &
CSO Stephen B. Friedman, Ph.D. Syntherica's mission is to use its
Synthetide(tm) technology to create a new class of therapeutics for
the treatment of human disease. In the near term, however, the Company
plans to use Synthetides(tm) in applications that have a shorter time
to market than therapeutics, such as drug discovery, medical
diagnostics, toxic chemical detection, pathogen detection,
environmental testing and food safety.

Note to presenting companies: to issue your trade show or conference news, contact your local Business Wire bureau at 888/381-9473.